|
Volumn 6, Issue 6, 2000, Pages 741-748
|
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
LAMIVUDINE;
VIRUS DNA;
ADULT;
AGED;
ARTICLE;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
FEMALE;
HEPATITIS B;
HUMAN;
IMMUNOPROPHYLAXIS;
LIVER TRANSPLANTATION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RECURRENT INFECTION;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
|
EID: 0033743167
PISSN: 15276465
EISSN: None
Source Type: Journal
DOI: 10.1053/jlts.2000.18702 Document Type: Article |
Times cited : (218)
|
References (31)
|